期刊文献+

p16,p15及pRb在表皮肿瘤中的表达 被引量:2

Expressions of p16, p15 and pRb in Neoplasms of Epidermis
下载PDF
导出
摘要 目的检测p16、p15及pRb在表皮肿瘤(基底细胞癌,角化棘皮瘤,脂溢性角化病等)中的表达及相互关系,以探讨它们在表皮肿瘤中发生、发展中的作用。方法用S-P免疫组化染色法检测34例基底细胞癌(BCC),12例角化棘皮瘤(KA),11例脂溢性角化病及10例正常皮肤中p16,p15及pRb蛋白的表达。结果p16、p15及pRb在基底细胞癌中均有不同程度失表达,分别为11/34(32.4%),15/34(44.1%)及10/34(29.4%);除1例脂溢性角化病pRb蛋白阴性表达外,12例角化棘皮瘤,11例脂溢性角化病及10例正常皮肤中p16、p15及pRb蛋白均呈阳性表达;基底细胞癌中,部分肿瘤p16,p15的表达与pRb蛋白的表达呈负相关,即一方的表达伴另一方的不表达。结论p16、p15及/或pRb的表达异常可能与基底细胞癌的发生、发展有关;但与表皮良性肿瘤的发生无关。 Objective To detect the expressions and relationships of p16,p15 and pRb in several neoplasms of epidermis e.g. basal cell carcinomas(BCC), keratoacanthomas,seborrheic keratoses , and to explore their roles in the development and advance of epidermal tumors . Methods The expressions of p16,p15 and pRb in 34 BCCs,12 keratoacanthomas,11 seborrheic keratoses and 10 normal skin specimens were detected by S-P immunohistochemical staining. Results Loss expressions p16、p15 and pRb were seen in 11 (32.3%); 15 (44.1%) and 10 (29.4%) cases of 34 BCCs , respectively; whereas positive expressions of them were observed in almost all 12 keratoacanthomas,11 seborrheic keratoses and 10 normal epidermises except loss expressions of pRb in 1 seborrheic keratosis;In some BCCs,there was an inverse correlation between the expressions of p16 or p15 and pRb,namely expressions of p16 or p15 were accompanied by loss expression of pRb ,and the vice versa. Conclusions The abnormal expressions of p16、p15 and/or pRb may be related to the development and advance of BCCs, but unrelated to the development of the benign neoplasms of epidermis.
出处 《国际医药卫生导报》 2004年第24期6-8,共3页 International Medicine and Health Guidance News
关键词 P16 P15 PRB 表皮肿瘤 免疫组化染色 p16 p15 pRb Neoplasma Epidermis Immunohistochemical staining
  • 相关文献

参考文献8

  • 1Geradts J .,Kratzke RA., Niehans GA., et al. Immunohistochemical detection of cyclin-dependent kinase inhibitor2/Multiple tumor suppressor genel (CDNK2/MTS1)product p16INK4A in archival human solid tumor:Correlation with retinoblastoma protein expression. 被引量:1
  • 2Saridaki z., Koumantaki E., Liloglou T., et al High frequency of loss of heterozygosity on chromosome region 9p21-22 but lack of p16(INK4a)/p19(ARF) mutations in Greek patients with basal cell carcinoma of the skin. J Invest Dermatol ,2000, 15:719~725 被引量:1
  • 3Kamb A., Gruis NA., Weaver Feldhaus J., et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 1994, 264(5157):436-4 被引量:1
  • 4Musgrove EA ,Lilischkis R., Cornish AL.,et al. Expression of the cyclin-dependent kinase inhibitorsp16INK4, p15INK4B and p21WAF1/CIP1 in human breast cancer. Int J Cancer, 1995, 63:584-591 被引量:1
  • 5Serrano M., Hannon GJ., Beach D A. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Natue, 1993,366:704-707 被引量:1
  • 6Shapiro GI.,Edwards CD., Kobzik L., et al. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancer and cell lines. Cancer Res , 1995;55:505-509 被引量:1
  • 7Soufir N., Moles J.P., Vilmer C., et al. p16 UV mutation in skin epithelial tumors. Oncogene , 1999,18:5477-81 被引量:1
  • 8Kubo Y., Urano Y., Fukuhara K., et al Lack of mutation in the INK4a locus in basal cell carcinomas.Br J Dermatol , 1998, 139:340-341 被引量:1

同被引文献36

  • 1魏志平,刘彦群,张昕博.p16基因甲基化及P16、Cyclin D1、pRb与皮肤鳞状细胞癌相关性研究[J].徐州医学院学报,2006,26(1):75-79. 被引量:2
  • 2Hsu JW,Hsu SL,Chu JJ,et al.Increased NM23: MTS1 ratio inversely correlated with metastasis behaviour in human lung squamous cell carcinoma. Anticancer Research . 1997 被引量:1
  • 3Marx J.A challenge to p16 gene as a major tumor suppressor. Science . 1994 被引量:1
  • 4Serrano M,Hannon GJ,Beach DA.New regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature . 1993 被引量:1
  • 5Norbury C,Nurse P.Animal cell cycles and their control. Annual Review of Biochemistry . 1992 被引量:1
  • 6Parry D,Bates S,Mann DJ,et al.Lack of cyclin d-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTSI tumour suppressor gene product. EMBO Journal . 1995 被引量:1
  • 7Lukas J,Aagaard L,Strauss M,et al.Oncogenic aberrations of p16 ink4/CDKN2 and cyclinD1 cooperate to deregulate G1 control. Cancer Research . 1996 被引量:1
  • 8Liu Y,Sharpless NE.Tumor suppressor mechanisms in immuneaging. Current Opinion in Immunology . 2009 被引量:1
  • 9Brown,JM,Harwood,CA,Crook,T.p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. Journal of Investigative Dermatology . 2004 被引量:1
  • 10M.S. Greenblatt,J.G. Beaudet,J.R. Gump,K.S. Godin,L. Trombley,J. Koh,J.P. Bond.Detailed computational study of p53 and p16: Using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants. Oncegene . 2003 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部